semaglutide for weight loss healthy now md & MedSpa Semaglutide, a popular weight loss

PlexusDx's Precision Peptide Genetic Test focuses on peptide-pathway predispositions (such as GLP1R, GIPR, and metabolic variants like FTO and MC4R), which relate to appetite regulation and metabolic health

To date, subcutaneous semaglutide 2.4 mg/week is the first GLP-1RA approved by the US Food and Drug Administration (FDA) in August 2025 and by the European Medicines Agency (EMA) in March 2026 for the treatment of adults with non-cirrhotic MASH and moderate-to-advanced liver fibrosis (stage F2-F3)

This normalization can result in improved sleep quality, mood stabilization, and enhanced cognitive function Anisimov et al., Neuroendocrinol Lett , 2001

When it comes to dosage this is relative and will depend on your body weight and needs after a physicians evaluation